Methadone Is Associated With Superior Long-Term Treatment Retention Compared With Buprenorphine/ Naloxone in a Large Canadian Cohort
Journal of Studies on Alcohol and Drugs · 2026-11 · 87 (6) · 1103-1112
DOI: 10.15288/jsad.26-00065 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Studies on Alcohol and Drugs, 2026-11. Verfasst von Kristen A Morin und 7 weiteren Autor:innen. Beteiligte Einrichtung: NOSM University, Sudbury, Ontario, Canada. Hauptthemen laut MEDLINE: Methadone, Opioid-Related Disorders, Buprenorphine, Naloxone Drug Combination, Opiate Substitution Treatment. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- NOSM University, Sudbury, Ontario, Canada.
- Health Sciences North Research Institute/L'Institut de recherches d'Horizon Santé-Nord, Sudbury, Ontario, Canada.
- ICES North, Sudbury, Ontario, Canada.
- Public Health Sudbury & Districts, Sudbury, Ontario, Canada.
- Simon Fraser University, Burnaby, British Columbia, Canada.
Zitieren
APA
Morin, K. A., Tatangelo, M., Acharya, S., LaBrosse, D., Leary, T., Thiyagaratnam, D., Nosyk, B., & Marsh, D. C. (2026). Methadone Is Associated With Superior Long-Term Treatment Retention Compared With Buprenorphine/ Naloxone in a Large Canadian Cohort. Journal of Studies on Alcohol and Drugs, 87(6), 1103-1112. https://doi.org/10.15288/jsad.26-00065
Vancouver
Morin KA, Tatangelo M, Acharya S, LaBrosse D, Leary T, Thiyagaratnam D, et al. Methadone Is Associated With Superior Long-Term Treatment Retention Compared With Buprenorphine/ Naloxone in a Large Canadian Cohort. Journal of Studies on Alcohol and Drugs. 2026;87(6):1103-1112. doi:10.15288/jsad.26-00065
BibTeX
@article{Morin2026,
author = {Morin, Kristen A and Tatangelo, Mark and Acharya, Shreedhar and LaBrosse, Danielle and Leary, Tara and Thiyagaratnam, Dilusha and Nosyk, Bohdan and Marsh, David C},
title = {Methadone Is Associated With Superior Long-Term Treatment Retention Compared With Buprenorphine/ Naloxone in a Large Canadian Cohort},
journal = {Journal of Studies on Alcohol and Drugs},
year = {2026},
volume = {87},
number = {6},
pages = {1103--1112},
doi = {10.15288/jsad.26-00065}
}
EUVIMED